Do Fast Track Regulatory Pathways Mean Quicker Reimbursement For Gene Therapies?

 
• By Francesca Bruce

The norms on securing market access are being rewritten for cell and gene therapies.

Fast Track
Accelerated regulatory pathyways can throw up evidentiary challenges for reimbursement • Source: Alamy

More from Product Reviews

More from Pink Sheet